Nondrug costs of therapy in acute care--are they important?
- PMID: 14624680
- PMCID: PMC374388
- DOI: 10.1186/cc2403
Nondrug costs of therapy in acute care--are they important?
Abstract
Drug acquisition costs are only a proportion of the total costs associated with drug therapy. The relevance of these costs are often not appreciated. However, they impact on the Intensive Care Unit via resources and quality of care. Increased indirect care by medical and nursing staff has the potential to adversely affect patient outcome. Redirecting staff to their primary role and reducing indirect patient activities will increase quality and allow more patients to be treated. Costs and resources are increasingly important in health care provision.
Comment on
-
Importance of nondrug costs of intravenous antibiotic therapy.Crit Care. 2003 Dec;7(6):R184-90. doi: 10.1186/cc2388. Epub 2003 Oct 14. Crit Care. 2003. PMID: 14624694 Free PMC article.
References
-
- Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ, Jr, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699–709. doi: 10.1056/NEJM200103083441001. - DOI - PubMed
-
- Angus DC, Linde-Zwirble WT, Clermont G, Ball DE, Basson BR, Ely EW, Laterre PF, Vincent JL, Bernard G, van Hout B, PROWESS Investigators Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis. Crit Care Med. 2003;31:1–11. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical